Complications of advanced prostate cancer

Urology

Volumn 54, Issue 6 SUPPL. 1, 1999, Pages 8-14

  Smith Jr , Joseph A ^a   Soloway, Mark S ^b   Young, Marvin J ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; DEXAMETHASONE; DIURETIC AGENT; DOCETAXEL; ERYTHROPOIETIN; ESTRAMUSTINE; HEPARIN; IRON; MITOXANTRONE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PLACEBO; PREDNISOLONE; PREDNISONE; STEROID;

ANEMIA; BLADDER OBSTRUCTION; BONE PAIN; CANCER PAIN; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; EDEMA; FRACTURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPINAL CORD COMPRESSION; URETER OBSTRUCTION;

EID: 0032760986     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00448-3     Document Type: Article

References (30)

1. Schroder F.H. Endocrine treatment of prostate cancer. Walsh P.C., Retik A.B., Vaughan E.D., Wein A.J. Campbell's Urology, vol 3. 1998;2627-2644 WB Saunders Company, Philadelphia.
2. Benson R.C. Jr, Hasa S.M., Jones A.G., et al. External beam radiotherapy for palliation of pain from metastatic carcinoma of the prostate. J Urol. 127:1982;69-71.
3. Salazar O.M., Rubin P., Hendrickson F.R., et al. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Cancer. 58:1986;29-36.
4. Epstein L.M., Steward B.H., Antunez A.R., et al. Half and total body radiation for carcinoma of the prostate. J Urol. 122:1979;330-332.
5. Brundage M.D., Crook J.M., Lukke H. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group. Cancer Prev Control. 2:1998;79-87.
6. Ben-Josef E., Porter A.T. Radioisotopes in the treatment of bone metastases. Ann Med. 29:1997;31-35.
7. Smith J.A. Jr. Palliation of painful bone metastases from prostatic cancer using sodium etidronate. J Urol. 141:1989;85-87.
8. Adami S: Bisphosphonates in prostate carcinoma. Cancer 80(Suppl 8): 1674-1679, 1997.
9. Schultz M., Wei J., Picus J., Cochran J. A phase II trial of docetaxel in patients with hormone refractory prostate cancer (HRPC), (abstract #1320). Proc Am Soc Clin Oncol. 18:1999;355a.
10. Eisenberger M.A. Chemotherapy for hormone-resistant prostate cancer. Walsh P.C., Retik A.B., Vaughan E.D., Wein A.J. Campbell's Urology, vol 3. 1998;2645-2658 WB Saunders Company, Philadelphia.
11. Petrylak D.P., Macarthur R.B., O'Connor J., et al. Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer. J Clin Oncol. 17:(3):1999;958-967.
12. Kreis W., Budman D.R., Fetten J., Gonzales A.L., Barile B., Vinciguerra V. Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma. Ann Oncol. 10:1999;338.
13. Tannock I.F., Osoba D., Stockler D., et al. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer a Canadian randomized trial with palliative end points . J Clin Oncol. 14:1996;1756-1764.
14. Twycross R.G. The management of pain in cancer a guide to drugs and dosages . Oncology. 2:1988;35-43.
15. Kantor T.G. Control of pain by nonsteroidal antiinflammatory drugs. Med Clin North Am. 66:1982;1053-1059.
16. Foley K.M. The treatment of pain in the patient with cancer. CA Cancer J Clin. 36:1986;194-215.
17. Moertel C.G. Treatment of cancer pain with orally administered medications. JAMA. 244:1980;2448-2450.
18. Coyler R.A. Surgical stabilization of pathological neoplastic fractures. Curr Probl Cancer. 10:1986;117-168.
19. Fleischmann J.D., Catalona W.J. Endocrine therapy for bladder outlet obstruction from carcinoma of the prostate. J Urol. 134:1985;498-500.
20. Varenhorst E., Alund G. Urethral obstruction secondary to carcinoma of the prostate response to endocrine treatment . Urology. 25:1985;354-356.
21. Smith J.A. Jr, Middleton R.G. Clinical Management of Prostatic Cancer. 1987;Year Book Medical, Chicago.
22. Michigan S., Catalona W.J. Ureteral obstruction from prostatic carcinoma response to endocrine and radiation therapy . J Urol. 118:1977;733-738.
23. Megalli M.R., Gursel E.O., Demirag H., et al. External radiotherapy I ureteral obstruction secondary to locally invasive prostatic cancer . Urology. 3:1974;562-564.
24. Rubin H., Lome L.G., Presman D. Neurological manifestation of metastatic prostatic carcinoma. J Urol. 111:1974;799-802.
25. Iacovou J.W., Marks J.C., Abrams P.H., et al. Cord compression and carcinoma of the prostate is laminectomy justified? Br J Urol. 57:1985;733-736.
26. Kuban D.A., El-Mahdi A.M., Sigfred S.V., et al. Characteristics of spinal cord compression in adenocarcinoma of prostate. Urology. 28:1986;364-369.
27. Modic M.T., Masaryk T., Paushter D. Magnetic resonance imaging of the spine. Radiol Clin North Am. 24:1986;229-245.
28. Young F.R., Post E.M., King G.A. Treatment of spinal epidural metastases. J Neurosurg. 53:1980;741-748.
29. Constans J.P., de Divitiis E, Donzelli R., et al. Spinal metastases with neurological manifestations. J Neurosurg. 59:1983;111-118.
30. Pergament M.L., Swaim W.R., Blackard C.E. Disseminated intravascular coagulation in the urologic patient. J Urol. 116:1976;1-6.